Golitsyn Sp - Concepedia

Author

Golitsyn Sp

National Medical Research Center of Cardiology ORCID

Also Known As

Britta Goldmann, D. Bonderman, G P Ma, G.P. Ma, Gilbert Ifechukwu P, Gilbert Ifechukwu P., Golitsyn Sergey P., Golitsyn Sp, Golubinskaya E.P., Gonzales Rizzenellie P.

264

Publications

13K

Citations

H-Index

Concepts

All Affiliations

National Medical Research Center of Cardiology Institute of Experimental Cardiology

About

Golitsyn Sp is an author at National Medical Research Center of Cardiology specializing in cardiology, public health, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	533
2	Public Health	9	9	533
3	Emergency Medicine	5	5	336
4	Cardiothoracic Surgery	1	1	212
5	Health Policy	1	1	124

Golitsyn Sp

Publications

785

Citations

H-Index

Page 1

	Year	Citations
2020 Clinical guidelines for Atrial fibrillation and atrial flutter M. S. Arakelyan, L.A. Bockeriа, Elena Vasilieva, Russian Journal of Cardiology Electrophysiological EvaluationCardiothoracic SurgeryStructural Heart DiseaseCardiovascular DiseaseRussian Society	2021	212
Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation Marc A. Vos, Golitsyn Sp, Karl Stangl, Heart	1998	199
Cardiovascular prevention 2022. Russian national guidelines S. А. Boytsov, Nana Pogosova, Yu. A. Vasyuk, Russian Journal of Cardiology HypertensionPreventive MedicineCardiovascular EpidemiologyCardiovascular DiseaseHealth Policy	2023	124
Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines N. M. Neminuschiy, V. V. Bereznitskaya, S. V. Garkina, Russian Journal of Cardiology Ventricular ArrhythmiasClinical GuidelinesRussian SocietyRussian Scientific SocietyElectrophysiological Evaluation	2021	72
Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness N. Yu. Mironov, V. V. Vlodzyanovskiy, Golitsyn Sp, Rational Pharmacotherapy in Cardiology Cardiac AnaesthesiaDevice TherapyCardiovascular PharmacologyPharmacotherapyThrombosis	2018	29
Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness N. Yu. Mironov, V. V. Vlodzyanovskiy, Golitsyn Sp, Rational Pharmacotherapy in Cardiology Cardiac AnaesthesiaTotal DoseCardiovascular PharmacologyPharmacotherapyCardiovascular Toxicity	2021	24
EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION Golitsyn Sp, L. Yu. Layovich, N. Yu. Mironov Eurasian heart journal ThrombosisElectrophysiological EvaluationCardiovascular DiseaseCoagulopathyAtrial Fibrillation	2019	20
2020 Clinical practice guidelines for Supraventricular tachycardia in adults L. A. Bokeria, R. E. Batalov, O. L. Bokeria, Russian Journal of Cardiology All-russian Scientific SocietyHeart FailureRussian FederationClinical Practice GuidelinesDiastolic Function	2021	19
Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter E. B. Maykov, N. Yu. Mironov, Golitsyn Sp, Terapevticheskii arkhiv	2015	18
The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design Yu. F. Osmolovskaya, Golitsyn Sp Rational Pharmacotherapy in Cardiology HypertensionHeart FailurePharmacotherapyStructural Heart DiseaseDiastolic Function	2015	17

Page 1